- Home
- CBAT vs MNOV Comparison
CBAT vs MNOV Comparison
Compare CBAT & MNOV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CBAT
- MNOV
- Stock Information
- Founded
- CBAT 1999
- MNOV 2000
- Country
- CBAT China
- MNOV United States
- Employees
- CBAT N/A
- MNOV N/A
- Industry
- CBAT Industrial Machinery/Components
- MNOV Biotechnology: Pharmaceutical Preparations
- Sector
- CBAT Miscellaneous
- MNOV Health Care
- Exchange
- CBAT Nasdaq
- MNOV Nasdaq
- Market Cap
- CBAT 71.6M
- MNOV 76.0M
- IPO Year
- CBAT N/A
- MNOV 2005
- Fundamental
- Price
- CBAT $0.68
- MNOV $1.26
- Analyst Decision
- CBAT
- MNOV Strong Buy
- Analyst Count
- CBAT 0
- MNOV 1
- Target Price
- CBAT N/A
- MNOV $9.00
- AVG Volume (30 Days)
- CBAT 158.7K
- MNOV 14.3K
- Earning Date
- CBAT 03-17-2025
- MNOV 05-08-2025
- Dividend Yield
- CBAT N/A
- MNOV N/A
- EPS Growth
- CBAT N/A
- MNOV N/A
- EPS
- CBAT 0.13
- MNOV N/A
- Revenue
- CBAT $176,614,609.00
- MNOV N/A
- Revenue This Year
- CBAT $28.79
- MNOV N/A
- Revenue Next Year
- CBAT $36.77
- MNOV N/A
- P/E Ratio
- CBAT $5.67
- MNOV N/A
- Revenue Growth
- CBAT N/A
- MNOV N/A
- 52 Week Low
- CBAT $0.71
- MNOV $1.12
- 52 Week High
- CBAT $2.08
- MNOV $2.55
- Technical
- Relative Strength Index (RSI)
- CBAT 24.84
- MNOV 28.65
- Support Level
- CBAT $0.71
- MNOV $1.31
- Resistance Level
- CBAT $0.90
- MNOV $1.53
- Average True Range (ATR)
- CBAT 0.05
- MNOV 0.05
- MACD
- CBAT -0.01
- MNOV -0.00
- Stochastic Oscillator
- CBAT 7.61
- MNOV 11.11
About CBAT CBAK Energy Technology Inc.
CBAK Energy Technology Inc is engaged in the manufacture, commercialization, and distribution of a variety of standard and customized lithium and sodium high-power rechargeable batteries. The batteries are used in light electric vehicles, electric vehicles, energy storage devices, and other high-power applications. The company has two operating segments: CBAK, which derives maximum revenue, and includes the manufacturing, commercialization, and distribution of various standard and customized lithium-ion rechargeable batteries; and the Hitrans segment, which includes the development and manufacturing of NCM precursor and cathode materials. Geographically, the company derives its key revenue from Mainland China, followed by Europe and other regions.
About MNOV Medicinova Inc
MediciNova Inc is a biopharmaceutical company. The company acquires and develops small-molecule therapeutics for the treatment of diseases with unmet medical needs with a specific focus on the U.S. market. Its products portfolio includes therapeutics such as MN-001, MN-166, MN-221 etc. The firm's current strategy is to focus its development activities on therapeutics for neurological disorders and fibrotic diseases.